Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 3 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
SaleCommon Stock | 100 | $534.74 | $53,474.00 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,460 Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
SaleCommon Stock | 14,011 | $533.73 | $7,478,091.03 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,560 F1 · price: This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
Exercise / conversionCommon Stock | 5,473 | $238.27 | $1,304,051.71 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:26 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
SaleCommon Stock | 2,432 | $500.46 | $1,217,118.72 |
DisclosureSEC source: 0001156039-24-000040 · wk-form4_1710275168.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,840 F1 · price: This transaction was executed in multiple trades at an exact price of $500.46. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:16 UTC |
Penczek Ronald WCAO & Controller
|
SaleCommon Stock | 916 | $504.58 | $462,195.28 |
DisclosureSEC source: 0001156039-24-000037 · wk-form4_1709932548.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,764 F1 · price: This transaction was executed in multiple trades at prices ranging from $504.56 to $504.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · derivative · entry 9 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,908 Underlying: Common Stock · 15,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
SaleCommon Stock | 15,000 | $500.18 | $7,502,700.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 7 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,887 F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023. F5 · price: This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
SaleCommon Stock | 1,889 | $500.18 | $944,840.02 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 6 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,887 F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023. F5 · price: This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
SaleCommon Stock | 4,206 | $500.18 | $2,103,757.08 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,776 F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023. F5 · price: This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Exercise / conversionCommon Stock | 15,000 | $166.97 | $2,504,550.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:32 UTC |
Penczek Ronald WCAO & Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 867 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000035 · wk-form4_1709674295.xml · derivative · entry 4 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 867 Underlying: Common Stock · 867 shares Expires 2034-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 867 shares, and is exercisable in three annual installments of 289 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:32 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 1,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000035 · wk-form4_1709674295.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,680 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. F4 · balance_after: Balance includes 4.20 shares acquired on December 21, 2023 through a dividend reinvestment plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:32 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 226 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000035 · wk-form4_1709674295.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,634 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 75 shares each on 3/1/2025 and 3/1/2026 and 76 shares on 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:32 UTC |
Penczek Ronald WCAO & Controller
|
Tax withholdingCommon Stock | 383 | $499.11 | $191,159.13 |
DisclosureSEC source: 0001156039-24-000035 · wk-form4_1709674295.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,408 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:29 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,312 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000033 · wk-form4_1709674162.xml · derivative · entry 4 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,312 Underlying: Common Stock · 8,312 shares Expires 2034-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:29 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
GrantCommon Stock | 6,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000033 · wk-form4_1709674162.xml · nonDerivative · entry 3 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,156 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:29 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
GrantCommon Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000033 · wk-form4_1709674162.xml · nonDerivative · entry 2 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,619 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 718 shares on 3/1/2025, 3/1/2026, and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:29 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Tax withholdingCommon Stock | 3,650 | $499.11 | $1,821,751.50 |
DisclosureSEC source: 0001156039-24-000033 · wk-form4_1709674162.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,465 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC |
LAVU RATNAKAREVP & Chief Digital Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,765 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000032 · wk-form4_1709674084.xml · derivative · entry 3 LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,765 Underlying: Common Stock · 6,765 shares Expires 2034-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 6,765 shares, and is exercisable in three annual installments of 2,255 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC |
LAVU RATNAKAREVP & Chief Digital Officer
|
GrantCommon Stock | 1,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000032 · wk-form4_1709674084.xml · nonDerivative · entry 2 LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,756 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 501 shares each on 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC |
LAVU RATNAKAREVP & Chief Digital Officer
|
GrantCommon Stock | 1,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000032 · wk-form4_1709674084.xml · nonDerivative · entry 1 LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,754 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 584 shares on 3/1/2025, and 585 shares each on 3/1/2026 and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,312 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000031 · wk-form4_1709674012.xml · derivative · entry 4 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,312 Underlying: Common Stock · 8,312 shares Expires 2034-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000031 · wk-form4_1709674012.xml · nonDerivative · entry 3 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,272 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantCommon Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000031 · wk-form4_1709674012.xml · nonDerivative · entry 2 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,918 F2 · shares: Represents restricted share units. Restrictions lapse as follows:718 shares on 3/1/2025, 3/1/2026, and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:27 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
Tax withholdingCommon Stock | 1,484 | $499.11 | $740,679.24 |
DisclosureSEC source: 0001156039-24-000031 · wk-form4_1709674012.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,764 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,280 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · derivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,280 Underlying: Common Stock · 9,280 shares Expires 2034-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
GrantCommon Stock | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,098 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
GrantCommon Stock | 2,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,946 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC |
Norwood Felicia FEVP & President,Gov Health Ben
|
Tax withholdingCommon Stock | 4,902 | $499.11 | $2,446,637.22 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,541 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,280 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · derivative · entry 8 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,280 Underlying: Common Stock · 9,280 shares Expires 2034-03-01 F6 · derivative.exercise_date: The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
GrantCommon Stock | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,982 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
GrantCommon Stock | 2,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,830 F2 · shares: Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Tax withholdingCommon Stock | 4,314 | $499.11 | $2,153,160.54 |
DisclosureSEC source: 0001156039-24-000029 · wk-form4_1709673865.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,425 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:22 UTC |
Kaye MarkEVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,633 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000027 · wk-form4_1709673760.xml · derivative · entry 2 Kaye Mark · CIK 0001748691 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,633 Underlying: Common Stock · 10,633 shares Expires 2034-03-01 F2 · derivative.exercise_date: The option represents a right to purchase a total of 10,633 shares, and is exercisable in two installments of 3,544 shares each, and one installment of 3,545 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:22 UTC |
Kaye MarkEVP & CFO
|
GrantCommon Stock | 2,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000027 · wk-form4_1709673760.xml · nonDerivative · entry 1 Kaye Mark · CIK 0001748691 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,031 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 918 shares each on 3/1/2025 and 3/1/2026 and 919 shares on 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:21 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 32,480 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000026 · wk-form4_1709673632.xml · derivative · entry 5 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,480 Underlying: Common Stock · 32,480 shares Expires 2034-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 32,480 shares, and is exercisable in one installment of 10,826 shares and two installments of 10,827 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:21 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantCommon Stock | 34,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000026 · wk-form4_1709673632.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,709 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. F4 · balance_after: Balance includes 392.27 shares acquired on 3/24/2023, 389.71 shares acquired on 6/23/2023 and 388.21 shares acquired on 9/23/2023 through a dividend reinvestment plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:21 UTC |
BOUDREAUX GAILDirector · President and CEO
|
GrantCommon Stock | 8,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000026 · wk-form4_1709673632.xml · nonDerivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,192 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 2,805 shares each on 3/1/2025, 3/1/2026, and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:21 UTC |
BOUDREAUX GAILDirector · President and CEO
|
Tax withholdingCommon Stock | 19,256 | $499.11 | $9,610,862.16 |
DisclosureSEC source: 0001156039-24-000026 · wk-form4_1709673632.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,777 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:22 UTC |
PERU RAMIRO GDirector
|
SaleCommon Stock | 753 | $500.00 | $376,500.00 |
DisclosureSEC source: 0001156039-24-000012 · wk-form4_1707513767.xml · nonDerivative · entry 1 PERU RAMIRO G · CIK 0001192045 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,109 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 3, 2023. F2 · price: This transaction was executed in multiple trades, each at the same price of $500.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:26 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Tax withholdingCommon Stock | 397 | $480.49 | $190,754.53 |
DisclosureSEC source: 0001156039-24-000002 · wk-form4_1704489960.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,115 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:28 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,492 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-23-000124 · wk-form4_1702675726.xml · derivative · entry 3 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,746 Underlying: Common Stock · 5,492 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:28 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
SaleCommon Stock | 5,492 | $484.02 | $2,658,237.84 |
DisclosureSEC source: 0001156039-23-000124 · wk-form4_1702675726.xml · nonDerivative · entry 2 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,512 Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:28 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Exercise / conversionCommon Stock | 5,492 | $311.48 | $1,710,648.16 |
DisclosureSEC source: 0001156039-23-000124 · wk-form4_1702675726.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:31 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Tax withholdingCommon Stock | 116 | $483.12 | $56,041.92 |
DisclosureSEC source: 0001156039-23-000121 · wk-form4_1701811863.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,512 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 01, 2023 Filed Jan 7, 2025 21:22 UTC |
Todt Blair WilliamsEVP, CLO & CAO
|
Tax withholdingCommon Stock | 1,127 | $483.12 | $544,476.24 |
DisclosureSEC source: 0001156039-25-000003 · wk-form4_1736284937.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP, CLO & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,029 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Due to administrative error, this transaction was not previously reported on a Form 4. As a result, the reporting person's Forms 4 filed since the date of this transaction have overstated the reporting person's ownership by 1,127 shares. Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 21:21 UTC |
Penczek Ronald WCAO & Controller
|
SaleCommon Stock | 1,055 | $475.17 | $501,304.35 |
DisclosureSEC source: 0001156039-23-000118 · wk-form4_1701465682.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,787 F1 · price: This transaction was executed in multiple trades at prices ranging from $475.05 to $475.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:44 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Tax withholdingCommon Stock | 154 | $446.66 | $68,785.64 |
DisclosureSEC source: 0001156039-23-000115 · wk-form4_1699044259.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,739 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:42 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
Tax withholdingCommon Stock | 79 | $446.66 | $35,286.14 |
DisclosureSEC source: 0001156039-23-000114 · wk-form4_1699044134.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,248 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 20:15 UTC |
Penczek Ronald WCAO & Controller
|
SaleCommon Stock | 64 | $454.35 | $29,078.40 |
DisclosureSEC source: 0001156039-23-000111 · wk-form4_1698351305.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,842 F1 · balance_after: Balance includes 7.99 shares acquired on March 24, 2023, 7.93 shares acquired on June 23, 2023 and 7.90 shares acquired on September 22, 2023 through a dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.